उत्पाद विवरण
Pomalong 2 mg capsule is a targeted treatment designed to combat multiple myeloma, a complex form of blood cancer, particularly in patients who have undergone at least two prior therapies, including lenalidomide and a proteasome inhibitor. As an immunomodulatory agent, Pomalong works by enhancing the immune system's ability to fight cancer cells, thus promoting a more effective therapeutic response. Patients should be aware that Pomalong can lead to potential side effects, including but not limited to low blood cell counts, which may increase the risk of infections and bleeding. Its crucial to monitor blood levels regularly while on this medication to ensure safety and efficacy. Additionally, individuals with a history of blood clots or those taking anticoagulants should consult their healthcare provider before starting treatment. Pomalong is available in capsule form, making it easy to incorporate into daily routines. This innovative therapy represents a significant advancement in the management of multiple myeloma, providing hope for improved outcomes in challenging cases. Always discuss with your healthcare professional to determine if Pomalong is the right choice for your treatment plan.